Market Place
Sourcing Support
Sun Pharm`s Generic Saxagliptin HCL Receives Tentative Approval In Us
05 Mar 2020 //
FDA
Merck`s DPP-4 newcomer Marizev trails Januvia in safety: Report
15 Apr 2016 //
FIERCE PHARMA
Colombian government recommendation puts Novartis cancer drug patent at jeopardy
08 Mar 2016 //
STAT
FDA warning on J&J`s Invokana adds more complexities to diabetes drug battles
12 Sep 2015 //
FIERCE PHARMA
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
29 Aug 2015 //
REUTERS
India rejects Lee Pharma’s compulsory licence plea
18 Aug 2015 //
THE ECONOMIC TIMES
High Court rejects AstraZeneca’s diabetes drug plea
29 Jul 2015 //
THE ECONOMIC TIMES
AstraZeneca, Dr Reddy`s ink diabetes drug distribution pact
30 May 2015 //
THE ECONOMIC TIMES
AstraZeneca`s Onglyza `Mortality` Risks Noted By FDA Reviewers
13 Apr 2015 //
FIERCE PHARMA
AZ`s Onglyza Has Most to Lose at FDA Safety Confab, Analysts Say
10 Apr 2015 //
FIERCE PHARMA
Astrazeneca Bullish on Diabetes Franchise Fortunes
13 Mar 2015 //
PMLIVE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.